Rilpivirine

ATC J05AG05 · 10 markets · 60 records

Rilpivirine 10 markets · 60 records Forms

AU 12 records · 5 strengths

25 mgtabletEDURANT+2Juluca、ODEFSEY also in US·GB·CA +3
900 mg/3 mLinjection · extended-releaseCabenuva also in GB
900 mginjectionCABENUVA cabotegravir 600 mg/3 mL plus rilpivirine 900 mg/3 mL prolonged-release suspensions for injection vials unknown
600 mginjectionCABENUVA cabotegravir 600 mg/3 mL plus rilpivirine 900 mg/3 mL prolonged-release suspensions for injection vials unknown

Records without a stated strength · 1 Cabenuva、EDURANT、Juluca、ODEFSEY、RILPEMVI、TRILPIVI +3

US 9 records · 2 strengths

25 mgtabletCOMPLERA+6EDURANT、Juluca、ODEFSEY、Manufacturer: Laurus Labs Limited、Manufacturer: Mylan Pharmaceuticals Inc.、Manufacturer: Somerset Therapeutics, LLC also in AU·GB·CA +3
2.5 mgtabletEDURANT PED also in GB

GB 7 records · 3 strengths

25 mgtabletEDURANT+4Eviplera 200mg/25mg/245mg tablets、Juluca、ODEFSEY、Manufacturer: Gilead Sciences Ltd also in AU·US·CA +3
2.5 mgtabletEDURANT also in US
900 mg/3 mLinjection · extended-releaseRekambys 900mg/3ml prolonged-release suspension for injection vials also in AU

CA 6 records · 2 strengths

25 mgtabletCOMPLERA+3EDURANT、Juluca、ODEFSEY also in AU·US·GB +3
300 mgliquid · extended-releaseCabenuva

EU 6 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 EDURANT、Emtricitabine/Rilpivirine/Tenofovir Alafenamide Viatris、Eviplera 200mg/25mg/245mg tablets、Juluca、ODEFSEY、REKAMBYS +3

ES 5 records · 3 strengths

25 mgtabletEDURANT+2Eviplera 200mg/25mg/245mg tablets、ODEFSEY also in AU·US·GB +3
900 mginjection · extended-releaseREKAMBYS

Records without a stated strength · 1 Juluca

HK 5 records · 1 strengths

Records without a stated strength · 1 EDURANT、ODEFSEY、REKAMBYS PROLONGED-RELEASE SUSPENSION FOR INJECTION 600MG/2ML

TW 4 records · 3 strengths

25 mgtabletEDURANT+1恩臨®膜衣錠25毫克 also in AU·US·GB +3
300 mginjection · extended-releaseRekambys prolonged-release suspension for injection 300 mg/mL+1瑞卡必持續性藥效注射懸浮劑300毫克/毫升

Records without a stated strength · 1 Juluca、ODEFSEY、安以斯膜衣錠、滋若愷膜衣錠 +1

SG 2 records · 2 strengths

25 mgtabletODEFSEY also in AU·US·GB +3
300 mg/mLinjection · extended-releaseRekambys prolonged-release suspension for injection 300 mg/mL

MX 1 records · 1 strengths

Records without a stated strength · 1 REKAMBYS

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	ES	MX	TW	HK	EU
25 mg tablet	Manufacturer: Laurus Labs Limited ×2 Manufacturer: Mylan Pharmaceuticals Inc. Manufacturer: Somerset Therapeutics, LLC +4 COMPLERA EDURANT Juluca ODEFSEY	Manufacturer: Gilead Sciences Ltd EDURANT Eviplera 200mg/25mg/245mg tablets +2 Juluca ODEFSEY	COMPLERA EDURANT Juluca +1 ODEFSEY	EDURANT Juluca ODEFSEY	ODEFSEY	EDURANT Eviplera 200mg/25mg/245mg tablets ODEFSEY	not recorded	EDURANT 恩臨®膜衣錠25毫克	not recorded	not recorded
2.5 mg tablet	EDURANT PED	EDURANT	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
900 mg/3 mL injection · extended-release	not recorded	Rekambys 900mg/3ml prolonged-release suspension for injection vials	not recorded	Cabenuva	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
300 mg injection · extended-release	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	Rekambys prolonged-release suspension for injection 300 mg/mL 瑞卡必持續性藥效注射懸浮劑300毫克/毫升	not recorded	not recorded
300 mg liquid · extended-release	not recorded	not recorded	Cabenuva	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
900 mg injection · extended-release	not recorded	not recorded	not recorded	not recorded	not recorded	REKAMBYS	not recorded	not recorded	not recorded	not recorded
900 mg injection	not recorded	not recorded	not recorded	CABENUVA cabotegravir 600 mg/3 mL plus rilpivirine 900 mg/3 mL prolonged-release suspensions for injection vials	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
600 mg injection	not recorded	not recorded	not recorded	CABENUVA cabotegravir 600 mg/3 mL plus rilpivirine 900 mg/3 mL prolonged-release suspensions for injection vials	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
300 mg/mL injection · extended-release	not recorded	not recorded	not recorded	not recorded	Rekambys prolonged-release suspension for injection 300 mg/mL	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	Cabenuva EDURANT Juluca +3 ODEFSEY RILPEMVI TRILPIVI	not recorded	not recorded	not recorded	not recorded	EDURANT ODEFSEY REKAMBYS PROLONGED-RELEASE SUSPENSION FOR INJECTION 600MG/2ML	EDURANT Emtricitabine/Rilpivirine/Tenofovir Alafenamide Viatris Eviplera 200mg/25mg/245mg tablets +3 Juluca ODEFSEY REKAMBYS
not disclosed tablet	not recorded	not recorded	not recorded	not recorded	not recorded	Juluca	not recorded	Juluca ODEFSEY 安以斯膜衣錠 +1 滋若愷膜衣錠	not recorded	not recorded
not disclosed liquid	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	REKAMBYS	not recorded	not recorded	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

4 more strength/form rows are recorded only in CA · SG · ES · MX and are not shown in this table. Hay 4 filas de concentración/forma registradas solo en CA · SG · ES · MX que no se muestran en esta tabla. 另有 4 个规格/剂型仅在 CA · SG · ES · MX 有记录（未在本表显示）。另有 4 個規格/劑型僅在 CA · SG · ES · MX 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.